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Abstract
Although progenitor cells of the conducting airway have been spatially localized and some insights have been
gained regarding their molecular phenotype, relatively little is known about the mechanisms regulating their main-
tenance, activation, and differentiation. This study investigates the potential roles of E-cadherin in mouse Clara
cells, as these cells were shown to represent the progenitor/stem cells of the conducting airways and have been
implicated as the cell of origin of human non–small cell lung cancer. Postnatal inactivation of E-cadherin affected
Clara cell differentiation and compromised airway regeneration under injury conditions. In steady-state adult lung,
overexpression of the dominant negative E-cadherin led to an expansion of the bronchiolar stem cells and de-
creased differentiation concomitant with canonical Wnt signaling activation. Expansion of the bronchiolar stem
cell pool was associated with an incessant proliferation of neuroepithelial body–associated Clara cells that ulti-
mately gave rise to bronchiolar hyperplasia. Despite progressive hyperplasia, only a minority of the mice developed
pulmonary solid tumors, suggesting that the loss of E-cadherin function leads to tumor formation when additional
mutations are sustained. The present study reveals that E-cadherin plays a critical role in the regulation of prolif-
eration and homeostasis of the epithelial cells lining the conducting airways.
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Introduction
Lung morphogenesis commences with the outgrowth of an endo-
dermally derived lung primordium that eventually forms the primitive
trachea and bronchi. In response to signals from the mesenchyme, the
primitive bronchi undergo repetitive rounds of budding and stereo-
typic branching to form the architecture of the lung. During this pro-
cess, differentiation of distinct respiratory epithelial cell types occurs
progressively in the perinatal and postnatal periods, producing the
various cells lining the conducting (basal, ciliated, Clara, and neuro-
endocrine cells) and peripheral (alveolar type I and type II cells) air-
ways. Cell differentiation during lung morphogenesis is regulated by
many factors including Wnt, Fgf, Shh, and BMP signaling [1].
After lung development, respiratory epithelium undergoes slow
homeostatic turnover resulting in the replacement of much of the
epithelium after 4 months in rodents [2]. Despite low cell turnover,
the respiratory epithelium is capable of extensive proliferation following
injury [3–7]. Cell type–specific injury models have identified several
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putative stem/progenitor cells residing in discrete niches along the
proximal-distal axis of the airways [7,8]. The endogenous stem cell
pools in normal adults usually respond to injury and starts tissue repair.
However, as adult stem cells are not immortal, this process is limited
and regeneration is incomplete. Besides, to aid a rapid repair, alveolar
epithelial cells (AECs) act as progenitor cells upregulating a stem/
progenitor cell marker during the recovery phase. This suggests that
either AECs contain a subpopulation of progenitor cells or the majority
of AECs can undergo reactivation into a progenitor-like state in
response to injury [9].
Clara cells represent an abundant population of long-term pro-
genitors that contribute to bronchiolar repair following injury to cil-
iated cells [10–13]. Within the normal lung, Clara cells maintain a
progenitor cell pool that needs to be stabilized for the sake of tissue
repair in case of injury. Clara cells can also undergo metaplasia to
mucous-producing cells restoring terminally differentiated cells of the
conducting airway epithelium [14]. Dose-dependent depletion of the
Clara cells in mice by naphthalene exposure revealed activation of rare
pollutant-resistant Clara cells [variant Clara (ClaraV)] that were local-
ized to the neuroepithelial body (NEB) and at the bronchoalveolar duct
junction (BADJ) [7,15,16]. Another subset of Clara cells that prolif-
erate following lung injury are bronchoalveolar stem cells (BASCs).
These cells are located at the BADJ microenvironment and were initially
identified by their co-expression of Scgb1a1 (marker of Clara cells) and
surfactant protein C (Sftpc) (alveolar type II cell marker) [17]. When
sorting these cells by flow cytometry (as Sca11, CD341 cells), they can
both self-renew in vitro and give rise to bronchiolar and alveolar cell
types. Furthermore, these cells are a target of activated Ras-mediated
neoplastic transformation in the mouse. More recently, deletion of p38
mitogen-activated protein (MAP) kinase in the adult lung was shown to
cause increased levels of proliferation in the alveoli at steady state, to cause
an increase in the number of dual-positive (CCSP1, SpC1) cells, and to
make the lung more susceptible to activated Ras-mediated oncogenic
transformation (45). Even though stem cells of the conducting airway
have been spatially localized and some insights have been gained regard-
ing their molecular phenotype, relatively little is known about the mech-
anisms regulating their maintenance, activation, and differentiation.
E-cadherin is a major component of adherens junctions between
epithelial cells and plays a pivotal role in epithelial differentiation dur-
ing embryonic development [18]. E-cadherin–deficient mice die very
early after the morula stage due to impaired trophectoderm formation
[19,20]. Tissue-specific ablation of E-cadherin in hair follicles or skin
of mice resulted in altered epidermal differentiation [21,22], whereas
in mammary glands impaired terminal differentiation was observed
after abrogation of E-cadherin expression [23]. In the lung, inhibiting
the ability of E-cadherin to form intercellular junctions in lung pri-
mordial explants has been shown to impair lung branching mor-
phogenesis [24]. We have recently demonstrated that disruption of
E-cadherin in mature alveolar type II cells leads to diffuse hyperplasia
and alveolar space enlargement [25]. These studies point to a role for
E-cadherin in lung epithelial differentiation and homeostasis in the
adult airways. In addition to its fundamental role in tissue morpho-
genesis, E-cadherin is frequently implicated in several types of human
cancer. Loss of E-cadherin has been commonly associated with tumor
progression by promoting invasive growth, angiogenesis, metastatic
dissemination, and colonization of tumor cells [25–27].
Hence, the aim of this study is to determine the function of
E-cadherin in differentiation and maintenance of the conducting air-
way epithelium by disrupting E-cadherin function in mouse Clara cells
in the adult lung. In addition, we also aimed to determine whether dis-
ruption of E-cadherin in Scgb1a1-expressing cells causes lung cancer.
Materials and Methods
For details of the experimental setup, see Supplementary Materials
and Methods.
Mouse Strains
Scgb1a1 rtTAmice were maintained on FVB/n background. Tet-O
dn E-cadherin transgenic mice were maintained on C57Bl/6 back-
ground. These transgenic mice have a truncated E-cadherin gene
where most of the extracellular domain of mouse E-cadherin was
excised. The transgene was preceded by a c-myc epitope and will be
referred to as dn E-cadherin [28]. Compound mice were induced with
doxycycline (DOX) containing food for different periods and ana-
lyzed for the phenotypic accuracy of lung pathology. All animal
experiments were performed according to the regulations of the Ba-
varian State authorities.
RNA Isolation and Reverse Transcription–Polymerase Chain
Reaction Analysis
Total RNA was isolated from whole lungs of mice, followed by
First-Strand c-DNA Synthesis Kit. Real-time reverse transcription–
polymerase chain reaction (RT-PCR) was performed using the DyNAmo
HS SYBR Green qPCR Kit in a Roto-Gene 2000 Detection System
with previously described primers [29–31].
Immunoblot Analysis
Protein was extracted from left lung lobes of mice. Immunoblot
analysis was performed using the following antibodies: myc tag
and actin.
Histopathology and Immunostainings
Immunohistochemistry and immunofluorescent staining were per-
formed on mouse lung paraffin sections using the following antibodies:
CYP2F2, Scgb1a1, Ki67, pro Sftpc, vimentin, E-cadherin, phospho-
Akt, phospho-ERK, activated β-catenin, myc tag, acetylated tubulin,
PGP 9.5, and β-catenin. For microscopy, we employed the Zeiss Axio
Scope.A1 or the Zeiss Discovery.V8 Stereo microscopes (Carl Zeiss
MicroImaging GmbH, Göttingen, Germany) integrated with an Axio-
Cam ICc3 camera (Spectra Service, Ontario, NY). Images were acquired
using AxioVision Rel. 4.7 software provided by Zeiss. Negative controls
included the omission of the primary antibody.
Morphometric Analysis
Quantitation of ciliated cells was assessed by determining the
length of basement membrane underlying tubulin+ regions of the
epithelium and dividing this value by the total length of the basement
membrane. Ciliated cells were scored from at least 10 bronchioles per
lung. Epithelial repair was quantified at day 2 and day 18 of treatment
recovery by determining the length of basement membrane under-
lying CYP2F2+ or Scgb1a1+ regions of the epithelium and dividing
this value by the total length of the basement membrane. The length
of the bronchial epithelium was determined using the measurement
function of Zeiss Axio Scope.A1. For quantitative assessment of
NEB-associated pulmonary neuroendocrine cells (PNECs) or ClaraV
cell proliferation, triple immunofluorescence staining was performed
on lung sections using CGRP, Scgb1a1, and Ki-67 antibodies. ClaraV
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cells were identified with their association with CGRP-expressing
neighboring NE cells.
Naphthalene Exposure
Five-week-old male compound (Scgb1a1 rtTA/Tet-O dn E-cadherin)
mice were intraperitoneally injected with 250 mg/kg body weight of
naphthalene (Sigma, Munich, Germany) dissolved in corn oil. Animals
were sacrificed 2 or 18 days following naphthalene or corn oil treatments.
BASC Sorting by Flow Cytometry
BASCs were isolated from the lungs of 6-week-old double-transgenic
(DTR) mice according to established protocols [17]. Isolated cells were
sorted using FACSCalibur (BD Immunocytometry Systems, Heidelberg,
Germany) according to the manufacturer’s instructions.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism 5
software (GraphPad Software, Inc, San Diego, CA). Student’s t test
(two-tailed) was used to compare two groups. When more than two
groups were compared, differences among the groups were deter-
mined by one-way analysis of variance. Differences between means
were considered statistically significant when P < .05.
Results
E-cadherin Is Necessary for Clara Cell Differentiation
in Steady-state Adult Lung
To determine the potential role of E-cadherin in murine lung non-
ciliated secretory epithelial cells (Clara cells), DTRmice were generated
by crossing Scgb1a1-rtTA mice with mice expressing a myc-tagged
dominant negative mutant of E-cadherin under the control of a
DOX-regulatable promoter (Tet-O dn E-cadherin–myc tag mice;
Figure 1A). The resulting compound mice were either untreated or
treated with DOX. Lung lysates obtained from adult DTR mice
showed expression of myc-tagged dn E-cadherin after 1 week DOX
administration in both the conducting and the alveolar portion of
Figure 1. Conditional inactivation of E-cadherin in steady-state lungs alters Clara cell differentiation. (A) Construct and breeding strategy
used to inactivate E-cadherin in Clara cells in the conducting airway. m, myc tag. (B) Immunoblot analysis shows transgene expression
only in the presence of DOX. Actin was used as a control. (C) Immunohistochemical staining of lung sections formyc tag. Five-week-old DTR
mice were either untreated (OFF DOX) or DOX-treated (ON DOX) for 1 week before analysis. Transgene expression was detected both in
conducting airways (red circles) and in the alveoli (green circles). Arrows in C indicate regions shown in insets. Hematoxylin (blue) was used
as a counterstain. Scgb1a1/myc tag (D) and Scgb1a1/E-cadherin (E) dual immunofluorescence stainings of lung sections from control and
induced adult mice. Myc tag–expressing Clara cells are shown with orange arrows. White arrows in D show Scgb1a1-negative but myc tag–
positive cells. Arrows in E indicate regions shown in insets. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI, blue).
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the airways after induction (Figure 1, B and C ). Furthermore, we ob-
served reduced endogenous E-cadherin level (Figure 1B) and lack of
endogenous E-cadherin expression in dn E-cadherin–expressing con-
ducting airway cells after induction (Figure W1). To show the specific
localization of dn E-cadherin expression in Clara cells, dual immuno-
fluorescence staining using myc tag and Scgb1a1 antibodies was per-
formed. In accordance with the activity of rat Scgb1a1 promoter in
adult lung [12], subsets of Clara cells were found to express myc-tagged
dn E-cadherin after induction (Figure 1D). Notably, we found that
some Clara cells that were negative for Scgb1a1 in conducting airway
epithelium stained positive for myc tag, suggesting that the inactivation
of E-cadherin alters Clara cell differentiation (Figure 1D). This decrease
in Scgb1a1 expression paralleled with the remarkable loss of E-cadherin
in both small and large conducting airways of the DOX-treated mice
(Figure 1E ).
To further evaluate the effect of loss of E-cadherin function on
bronchiolar epithelial cell differentiation, we have performed immuno-
fluorescence staining of ciliated cells using tubulin antibody that recog-
nizes ciliated cells. Induction of dn E-cadherin in respiratory epithelium
of the DOX-treated animals caused a significant decrease in the number
of ciliated cells (Figure 2, A and B). Analysis of three secretory cell–
specific mRNAs, Scgb1a1, CYP2F2, and FoxJ1 (a ciliated cell marker),
by quantitative RT-PCR supported the results of the immunofluores-
cence stainings and showed significantly lower mRNA abundance in
DOX-treated mice at all ages analyzed (Figure 2C ), whereas the abun-
dance of pro Sftpc mRNA, a marker for early lung epithelial progenitor
cells and alveolar type II cells, or Aquaporin-5 mRNA, a marker for
alveolar type I epithelial cells, did not vary between DOX-treated
and untreated DTRmice (Figure 2C). However, after DOX treatment,
we observed ectopic pro Sftpc expression within a small fraction of
conducting airways, a region of the lung where alveolar type II cells
are normally not found (Figure 2,D and E). Taken together, these data
demonstrate that overexpression of mutant E-cadherin leads to defec-
tive Clara cell epithelial differentiation and ectopic expression of pro
Sftpc in conducting airway epithelium.
Overexpression of dn E-cadherin in Clara Cells Attenuates
Epithelial Reparative Capacity in the Bronchioles
To determine whether signaling by E-cadherin is necessary for the
regeneration of conducting airway epithelium, 5-week-old DTR mice
were exposed to naphthalene, which causes site-selective injury to
mouse bronchiolar Clara cells [32], followed by a recovery phase of 2
and 18 days, respectively, in the presence or absence of DOX. Consis-
tent with earlier reports, conducting airway epithelium of DTR mice
treated with a single dose of naphthalene showed almost no Scgb1a1
immunoreactivity 2 days after injury compared to corn oil–treated
DTR mice (Figure 3A). Clusters of naphthalene-resistant and cycling
Scgb1a1-expressing cells that have been previously shown to serve as
regenerative foci [12] are maintained in the conducting airways
(Figure 3B). Notably, despite severe loss of Scgb1a1 expression, naph-
thalene treatment alone did not affect E-cadherin expression in the con-
ducting airways 2 days after injury in contrast to bronchioles of DTR
mice that were treated both with naphthalene and DOX simulta-
neously (Figure W2).
To analyze whether naphthalene-resistant cells of the bronchioles
are capable of appropriate epithelial renewal, conducting airways of
DTR mice were compared 18 days after administration of naphthalene
or corn oil. Efficacy of epithelial renewal within bronchioles was deter-
mined by counting CYP2F2 (Clara cell–specific marker) and Scgb1a1-
immunoreactive cells in untreated and naphthalene-treated animals.
As expected, no significant differences in the abundance of CYP2F2-
immunoreactive cells between corn oil and naphthalene-exposed
groups were observed (Figure 3, C and D). A dramatic reduction in
CYP2F2-immunoreactive cells was observed in the bronchioles of
DTRmice that were exposed to both naphthalene and DOX (Figure 3,
C and D) simultaneously. Similar data were obtained when Scgb1a1-
positive cells were scored (Figure 3E ). The CYP2F2-positive cells
within the bronchioles of naphthalene and DOX mice were also qual-
itatively different. Instead of uniform expression as observed in corn
oil– or naphthalene-only–treated mice, E-cadherin–deficient bronchi-
oles generally showed low level of CYP2F2 expression (Figure 3C ).
The low-level expression of CYP2F2 observed in these mice may reflect
abnormal development of Clara cells repopulating the airways due to
disruption in bronchiolar stem cells and differentiation. Alternatively,
reduction of CYP2F2 staining in naphthalene-treated E-cadherin–
deficient bronchioles (naphthalene and DOX) may arise from altered
differentiation of Clara cells (Figure 1D) rather than an impairment of
Clara cell regeneration. We therefore compared the level of CYP2F2-
expressing cells in DOX-induced DTRmice in the presence or absence
of naphthalene. Although there was a reduction in CYP2F2-positive
cells as early as 2 days after DOX treatment (Figure 3C), the inhibition
of Clara cell regeneration was much less severe than in naphthalene and
DOX–exposed animals (Figure 3,D and E). Notably, prolonged DOX
treatment in the absence of naphthalene exposure not only generated
conducting airways with low CYP2F2-expressing Clara cells but also
led to their expansion compared to other groups (Figure 3C). These data
demonstrate that expression of dn E-cadherin in Scgb1a1-expressing
cells affects restoration and differentiation of bronchiolar epithelium
after depletion of the Clara cell population.
Disruption of E-cadherin in Steady-state Adult Lungs Results
in an Abnormal Maintenance of Epithelial Cell Populations
in Multiple Progenitor Cell Niches
To determine whether the epithelial restoration defects arising from
loss of E-cadherin expression in conducting epithelium is associated
with abnormal maintenance of bronchiolar lung stem cells, we moni-
tored proliferation of ClaraV and PNE cells following naphthalene-
induced lung injury. As reported previously, acute Clara cell depletion
caused significant proliferation of ClaraV and PNE cells 2 days after
naphthalene exposure compared to the control group (Figure 4, A–C).
Consistent with restored bronchiolar epithelium, there was no dis-
cernable cell proliferation 18 days after recovery (Figure 4, A–C ).
Despite impaired epithelial renewal (Figure 3, D and E ), compara-
ble proliferation rates of ClaraV and PNE cells were found in mutant
E-cadherin–expressing conducting airways after naphthalene-induced
lung injury (Figure 4, A–C ). Interestingly, treatment of DTR mice
with DOX for 2 days also resulted in proliferation of ClaraV and
PNE cells in the absence of naphthalene treatment (Figure 4, A–C).
Moreover, in contrast to naphthalene-exposed animals, both ClaraV
and PNE cells continued to proliferate after prolongation of DOX
treatment for 18 days (Figure 4, A–C).
Another putative stem cell niche that was also found to be resistant
to naphthalene-induced toxicity is the BASCs [17]. The ectopic pro
Sftpc expression in the conducting airway epithelium (Figure 2D)
suggested that either the proximal-distal airway patterning was dis-
rupted or the number of specific cell types expressing pro Sftpc in the
conducting airway epithelium was increased. Loss of Scgb1a1 expression
in the alveolar epithelium argues against a simple loss of proximal-distal
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Figure 2. Disruption of E-cadherin in Scgb1a1-expressing cells impairs Clara cell lineage differentiation and induces ectopic expression
of pro SpC in conducting airways. (A) Representative dual immunofluorescence staining of lung sections for tubulin (red) and Scgb1a1
(green). Individual bronchioles are encircled by dashed lines. Nuclei were counterstained with DAPI (blue). (B) Morphometric analysis of
ciliated cells. Results are presented as means ± SEM for each group. *P < .05. BM, basement membrane. (C) Gene expression as a
function of age. Total lung RNA from control and induced mice was assayed for expression of Scgb1a1, cytochrome P450-2F2, FoxJ1,
SpC, and AQP-5 by quantitative RT-PCR, and average ddCT values are presented ± SEM. NB, new born. (D) Immunohistochemistry
shows ectopic expression of the alveolar type II cell marker pro Sftpc (red arrow) in bronchiolar epithelium of an induced mouse. Type II
pneumocytes (red asterisks) served as an internal control for pro Sftpc staining (brown). Hematoxylin (blue) was used as a counterstain.
(E) The percentage of terminal bronchioles containing zero, one, and two cells with ectopic pro Sftpc expression is shown. At least
220 bronchioles were counted from six DTR mice for each group. Results are presented as means ± SEM for each group. *P < .05.
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Figure 3. E-cadherin is necessary for the repair of conducting airway epithelium after injury. Five-week-old mice were treated as indi-
cated. Mice were recovered following 2 or 18 days from naphthalene or corn oil exposures. (A) Immunohistochemical staining of lung
sections for Scgb1a1. Images are representative of n = 4 separate mice per treatment group. Br, bronchiole. (B) Double immuno-
fluorescence staining of a lung section for Scgb1a1 (red) and Ki67 (green) shows actively proliferating naphthalene-resistant Clara cells
in bronchiolar epithelium of a medium airway (dotted line) 2 days after naphthalene treatment. Nuclei were counterstained with DAPI
(blue). (C) Immunohistochemical staining of lungs sections for CYP2F2. Red arrows indicate naphthalene-resistant Clara cells. Black
arrows and green brackets indicate Scgb1a1-negative regions. Insets represent higher magnification of the areas shown in boxed areas.
Blue circles indicate increased cellular densities. Hematoxylin (blue) was used as a counterstain. (D and E) Morphometric quantification
of the epithelial damage at day 2 and day 18 after naphthalene-mediated injury. The impact of treatment on epithelial repair was de-
termined through analysis of Scgb1a1 (E) or CYP2F2 (D) repopulation. Results are presented as means ± SEM for each group (n = 4).
*P < .05. BM, basement membrane.
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patterning. To assess whether the cells ectopically expressing pro Sftpc
also expressed Scgb1a1, dual immunofluorescence staining was per-
formed. Cells stained for Sftpc within the conducting airways were also
positive for Scgb1a1, indicating that these represented BASC-like
progenitor cells (Figures 5A). Despite ectopic localization, the level
of BASC-like progenitor cells was indistinguishable between the
DOX-treated and untreated groups (Figure 5, B and C), suggesting that
E-cadherin controls location rather than the expansion of this cell type.
Because activation of canonical Wnt signaling was shown to regulate
BASCs during lung epithelial regeneration [33], we sought to determine
the activation of β-catenin signaling in conducting airways after DOX
induction. Staining of lung sections with an antibody that specifically
detects the non-phosphorylated (stabilized) form of β-catenin did not
show discernible staining in corn oil–treated control mice (Figure W6A).
Consistent with activation of canonical Wnt/β-catenin signaling during
lung epithelial regeneration [33], acute naphthalene treatment of DTR
mice elicited nuclear β-catenin localization in naphthalene-resistant
Clara cells that was no longer detectable after airway restoration
(Figure W6, A and B). As in the case of naphthalene-treated animals,
we observed abundant β-catenin nuclear localizations in the majority of
the conducting airway cells after 2 days of DOX administration, indi-
cating activation of β-catenin signaling (Figure W6A). Conducting air-
way epithelial cells with nuclear β-catenin staining were also detected in
18-day DOX-induced DTR mice, albeit at low numbers (Figure W6B).
To determine whether the observed nuclear β-catenin localization de-
tected in lung sections from inducedDTRmice correlates with activation
of the known canonicalWnt target genes, we performed semiquantitative
RT-PCR and Western blot analysis. The results of these experiments
showed that expression of dn E-cadherin indeed activates this pathway
(Figure W6, C and D). Taken together, these data indicate that
E-cadherin plays an essential role in the regulation of bronchiolar stem
cells in a steady-state adult lung and its disruption affects differentiation
Figure 4. Analysis of cell proliferation within NEB regions under airway repair and steady-state conditions after E-cadherin inactivation.
(A) Triple immunofluorescence staining of lung sections for indicated markers. Naphthalene-resistant Clara cells (ClaraV) were identified
with their close association with CGRP-expressing neuroendocrine cells in NEBs. Asterisks show proliferating Clara cells that are NEB-
independent. Nuclei were counterstained with DAPI (blue). Quantitation of cell proliferation for PNECs (B) and for ClaraV cells (C) for
indicated treatment groups. Results are presented as average ± SEM for each group (n = 4). *P < .05.
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rather than the maintenance of these stem cells after airway injury pre-
sumably through activation of canonical Wnt signaling.
Loss of E-cadherin Function in Scgb1a1-expressing Cells
Causes Bronchiolar Hyperplasia that Are Rarely
Progressing to Lung Cancer
Continued proliferation of ClaraV cells as well as the hypercellularity
that we noted in the conducting airways of 18-day induced DTR
mice (Figure 3C ) suggested that loss of E-cadherin in the epithelium
of conducting airways elicits precancerous lesions. We therefore
screened a large cohort of DTR mice that were treated with different
DOX schedules for the incidence of hyperplasia. Focal epithelial
hyperplasia characterized by a hypercellular epithelium that protruded
into bronchial and bronchiolar lumens was observed as early as 2 weeks
of DOX treatment (Figure 7A). Such bronchiolar hyperplasia was rarely
detected in a very small fraction of the conducting airways of control
mice. This might be attributed to known off-target toxicity of rtTA or
low-level leakiness of the tet system (Figure 7B) [34]. In accordance
with the abnormal proliferation of ClaraV and PNE cells (Figure 4,
A–C ) in induced DTR mice, early focal hyperplastic lesions stained
positive for PGP 9.5, a marker for NE cells, and Scgb1a1, indicat-
ing that these preneoplastic lesions represent an expansion of these
Figure 5. Clara cell–specific loss of E-cadherin in adult lungs leads to ectopic BASC-like progenitor cell localization. (A) Representative
double immunofluorescence staining of lung sections for pro Sftpc (green) and Scgb1a1 (red) shows ectopic BASC-like progenitor cell
localizations (arrows) in an induced mouse compared to control. Yellow arrow indicates the region shown in the inset. Nuclei were
counterstained with DAPI (blue). (B) Gating strategy for FACS sorting. Cells were first gated on the CD31/CD45neg and CD34pos popu-
lation and then subsequently gated on the Sca1pos population. (C) Quantitation of flow cytometry for BASC-like progenitor cells between
the uninduced (OFF DOX) and 1-month DOX-induced (ON DOX) DTR mice (n = 3 mice for each group). Results are presented as means
± SEM for each group. ns, statistically not significant.
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progenitor cells (Figure 7C ). Analysis of transgene expression by immuno-
fluorescence staining showed that the majority of the hyperplastic
cells lost dn E-cadherin expression at this stage (Figure W3). Prolonga-
tion of DOX treatment led to the occurrence of an extensive papillary
hyperplasia throughout the conducting airways (Figure 7D). Consistent
with the loss of Scgb1a1 staining in dn E-cadherin–expressing Clara
cells (Figures 1D and 3E), immunohistochemical analysis showed that
the majority of cells in the hyperplastic regions were negative or weakly
stained for Scgb1a1 (Figure 7D). Similar to dn E-cadherin–expressing
conducting airway epithelium, most of the hyperplastic cells showed
nuclear β-catenin expression (Figure W4A). Despite activation of
canonical Wnt signaling in a certain fraction of hyperplastic cells, there
was no Sftpc or Sftpc/Scgb1a1 dual expressions in the hyperplastic
lesions (Figure W4B). To further identify the nature of the Scgb1a1-
negative cells in these hyperplastic regions, we stained them for markers
of ciliated and goblet cells, the other cell types that reside in the con-
ducting airways. Consistent with the loss of Clara cell differentiation,
there was no expansion of these cells in the preneoplastic lesions
(Figure W5, A and B).
Despite the progressive hyperplasia, multifocal pulmonary tumors
of epithelial origin were only observed in 3 of 28 induced DTR mice
analyzed between 10 and 18 months of age. Such multifocal lung
Figure 6. Activation of canonical Wnt signaling upon airway injury or as a consequence of dn E-cadherin expression in conducting air-
way epithelium. (A and B) Immunohistochemistry of lung sections for β-catenin. Duration and type of treatment as indicated. High-
magnification images represent regions shown in insets. Arrows show nuclear staining of β-catenin (brown). Hematoxylin (blue) was
used as a counterstain. (C) Semiquantitative RT-PCR analysis of Wnt/β-catenin–regulated genes for control (OFF DOX) and induced
(ON DOX) DTR mice. Actin was used as an internal control. (D) Immunoblot analysis of total lung lysates of control and induced
DTR mice with the indicated markers.
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tumors were never observed in control DTR or single transgenic mice.
As in the case of 2 of 27 control DTR mice, 3 animals from the re-
maining induced DTR mice developed single pulmonary foci remi-
niscent of spontaneous lung tumors. Histologic examination of lung
sections from multifocal tumor-bearing mice demonstrated solid lung
tumors, which were unevenly distributed between the lung lobes
(Figure 8A). Morphologically, these lung tumors resembled papillary
hyperplasias (Figure W6, A and B). Microscopic examination of
histopathology demonstrated that these tumors are malignant invasive
adenocarcinomas presenting a predominant papillary columnar growth
pattern with some additional micropapillary spots (Figure 8C). Stain-
ing of lung tumor sections with Ki67 antibody showed that most of the
tumor cells were actively proliferating (Figure 8A). Both columnar and
cuboidal lung tumors stained uniformly for TTF-1 but mostly lacked
Figure 7. Loss of E-cadherin expression in conducting airway epithelium leads to bronchiolar hyperplasia. (A) Histologic analysis through
H&E staining of lungs from control and 2-week DOX-treated DTR mice showing the presence of epithelial hyperplasia (arrow). (B) Quan-
titation of bronchiolar hyperplasia between the mice groups: wt, wild type (n = 13), (C) Scgb1a1-rtTA (n = 27), (D) Tet-O dn E-cadherin
(n= 23), DTR OFF DOX (n= 39), DTR ONDOX (n= 40); *P< .05. (C) Double immunofluorescence staining of the same lung sections from
A for indicated markers. Asterisk shows a PGP 9.5-positive NEB region. Marked region shows an expansion of an NEB region consisting of
PGP 9.5-and Scgb1a1-positive cells after induction. Nuclei were counterstained with DAPI (blue). (D) Immunohistochemical staining of lung
sections for Scgb1a1. Images are representative of n = 6 mice in each group. Hematoxylin (blue) was used as a counterstain.
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staining for Scgb1a1, indicating that tumors were not highly differen-
tiated (Figure 8B). Similar to the induced hyperplastic lesions, only a
minority of the tumor cells expressed the transgene (Figure W7A). Nei-
ther Scgb1a1 (Figure 8B) nor the transgene expression (Figure W7A)
was detected in spontaneous lung tumors. In treated DTR mice, the
two subtypes of multifocal lung tumors not only differed in their
morphology but also with respect to their pro Sftpc expression. Com-
pared to the uniform staining pattern of cuboidal tumors, only a minor
fraction of columnar tumors contained pro Sftpc–positive cells with cu-
boidal morphology, suggesting that cuboidal tumors arise from colum-
nar tumors by a dedifferentiation mechanism (Figure 8B). None of the
pro Sftpc–expressing tumor cells stained positive for Scgb1a1, indicat-
ing that these do not represent BASC-like progenitor cells (Figure 8C).
As in the case of the bronchiolar hyperplasia, tumor cells both from
cuboidal and columnar tumors did not contain ciliated or goblet cells
except the bronchiolar epithelium that is often embedded in the tumor
(Figure 8C). Although the majority of tumor cells lost the transgene
expression (Figure W7A), the great majority of the tumor cells lacked
E-cadherin but not β-catenin expression (Figure 8D). Interestingly, de-
spite the invasive features, tumor cells did not show detectable vimentin
expression or other epithelial-mesenchymal transition (EMT) markers
(Figure W8) after E-cadherin loss, indicating that EMT program was
not activated in tumor cells (Figure 8D). Consistent with the lack of
EMT, we did not detect disseminating tumor cells in other organs (data
not shown).
Low incidence of lung tumors as well as their maintenance in the
absence of the transgene expression supports the existence of addi-
tional genetic alterations. We therefore screened DNA samples from
individual lung tumors for the incidence of K-ras mutation, the most
frequent type of mutation found in human non–small cell lung cancer
Figure 8. Analysis of incidence and histopathology of pulmonary tumors from induced transgenic mice. (A) Lung sections from tumor-
bearing mice were either H&E stained or immunostained for Ki67 (brown). Arrows indicate tumor foci. (B) Immunohistochemistry of
tumor-bearing lung sections for lung differentiation markers as indicated. Arrows show rare Scgb1a1-positive tumor cells that were
never detected in spontaneous lung tumor but in their surrounding bronchioles. (C and D) Staining of lung tumor sections with the
indicated markers. Arrows in C show Alcian Blue–positive vessel and those in D show vimentin-positive vessel. Two representative
pictures were shown for each staining.
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(NSCLC). Sequencing of exons 1 and 2 of the K-ras gene demon-
strated an amino acid substitution at position 12, from glycine to
arginine (GGT→CGT, K-rasG12R). This mutation confers constitu-
tive activity of the ras-guanosine triphosphatase (GTPase). The G12R
mutation was undetectable in non-neoplastic regions of the lung and
the bronchiolar hyperplasia (Table 1). Consistent with K-rasG12R mu-
tation, lung tumors stained positive for the active form of Akt (pAkt)
and ERK (pERK), two downstream effectors of K-ras signaling
(Figure W7, B and C ). These results demonstrate that expression of
a dn E-cadherin mutant in the conducting airways induces the onset
of preneoplastic lung lesions that may predispose mice to lung cancer
after cooperating genetic alteration.
Discussion
In the present study, we have investigated the role of E-cadherin in
non-ciliated Clara cells of the bronchiolar airways as these cells were
shown to represent progenitor/stem cells of the conducting airways
and have been discussed as the cell of origin of human NSCLC
[35]. Our results demonstrate that E-cadherin is necessary for main-
tenance of Clara cell differentiation. Inactivation of E-cadherin im-
paired the repair of conducting airway epithelium after injury in
part by altering the differentiation potential of bronchiolar stem cells.
Loss of E-cadherin expression in steady-state adult lung caused pap-
illary epithelial cell hyperplasia in the bronchial and bronchiolar
lumens, providing evidence that E-cadherin is required for the normal
regulation of epithelial cell proliferation in the lung. Despite progres-
sive hyperplasia, formation of lung tumors was a rare event and re-
quired a cooperating genetic insult.
The respiratory epithelium of conducting airways plays a critical
role in pulmonary homeostasis, maintaining barrier function and ste-
rility. Previous studies have established an important role of canonical
Wnt signaling in lung development, lung cell differentiation, and lung
stem cell homeostasis. Three independent studies have shown that sta-
bilization of β-catenin in Clara cells causes loss of Scgb1a1 staining and
blocks Clara cell differentiation to the ciliated cell lineage [36–38]. In
line with nuclear β-catenin accumulation in conducting airway epithe-
lial cells, it is likely that the perturbation of Clara cell differentiation
upon expression of dn E-cadherin in Scgb1a1-expressing cells is me-
diated by activation of canonical Wnt signaling. Activation of Wnt/
β-catenin signaling following reduction in E-cadherin levels has previ-
ously been described in several model systems [39–41]. In addition to
perturbation of Clara cell differentiation, we detected pro Sftpc expres-
sion in the bronchioles of the E-cadherin–deficient mice. Interestingly,
ectopic pro Sftpc expression was also reported in a study in which a
non-degradable β-catenin was expressed in mouse Clara cells [37] fur-
ther supporting our observation of β-catenin activation in the DTR sys-
tem. Further characterization revealed that these cells have some
molecular similarities to BASCs. BASCs are regional stem cell popula-
tion in the distal lung and are normally located at BADJ. Transient
proliferation of BASCs at BADJ regions was reported to be a conse-
quence of naphthalene exposure [17]. Increased number of BASCs
was also reported upon forced expression of stabilized β-catenin in Clara
cells [33]. In the present work, despite activation of Wnt signaling and
appearance of BASC-like progenitor cells at ectopic sites, the total level
of BASC-like progenitor cells did not alter significantly between the
control and induced DTR mice. The failure in detecting increased
BASC-like progenitor cell numbers in induced DTR mice may result
from a low abundance of ectopic pro Sftpc expression in conducting
airways. Alternatively, there might be molecular differences between
ectopic BASC-like progenitor cells and BASCs that normally reside
at the BADJ in terms of the markers (CD31, CD45, CD34, Sca1) that
we used for sorting. If this would be the case, the ectopic pro Sftpc
expression may simply represent an altered differentiation rather than
true stem cell behavior. We do not yet understand the physiological
importance of these rare cells.
Genetic inactivation of E-cadherin in Scgb1a1-expressing epithelial
cells not only caused appearance of BASC-like progenitor cells at
ectopic sites but also resulted in generation of other immature cell
types such as NEB-associated Clara cells (ClaraV). The lack of Clara
and ciliated cells in conducting airways of induced DTRmice suggests
that the delicate balance between these progenitor/stem and differ-
entiated cells is impaired. The normal proliferation of ClaraV cells
during airway regeneration suggests that the airway repair defects
observed in DOX-treated (dn E-cadherin–expressing) DTR mice
resulted from failure of these stem cells to generate differentiated
epithelial cell types rather than their maintenance.
In contrast to what we observed after lung injury, postnatal loss of
E-cadherin function in conducting airways of the steady-state lung
resulted in a hyperproliferative response of ClaraV cells that led to
bronchiolar hyperplasia. The presence of incessantly dividing ClaraV
cells in these early hyperplastic foci suggested a bronchiolar stem cell
origin for these precancerous lesions. Under normal physiological
conditions, upon bronchiolar damage, i.e., naphthalene exposure,
NEB-associated ClaraV cells start to proliferate to renew conducting
airway epithelium. It is conceivable that loss of bronchiolar integrity
upon E-cadherin inactivation similarly evokes a repair response lead-
ing to the proliferation of ClaraV cells. In contrast to a normal repair
condition where NEB-associated ClaraV cells become quiescent after
renewal, unremitting proliferation of these progenitors in E-cadherin–
deficient conducting airway epithelium suggests that these bronchiolar
stem cells account for the observed bronchiolar hyperplasia.
Down-regulation of E-cadherin is a hallmark of most malignant
human tumors with epithelial origin including lung cancer. Frequent
loss of E-cadherin has been observed in human intrabronchial lesions
during carcinogenesis of the bronchial epithelium [42]. In the current
study, although the majority of the mice developed bronchiolar hyper-
plasia to different degrees, the incidence of pulmonary tumors was low.
Formation of rare pulmonary tumors was also reported in transgenic
mice in which an activated form of β-catenin [CatnbΔ(ex3)] was ex-
pressed in Clara cells [37]. Lack of progression from hyperplasia to overt
lung tumors in the majority of the animals in the present model might
result from loss of Scgb1a1 expression. Earlier studies have shown that
down-regulation of Scgb1a1 is an early event during pulmonary carci-
nogenesis and only a small percentage of tumor cells expresses Scgb1a1
[43]. Despite a selective advantage of Scgb1a1 down-regulation during
lung cancer progression, this loss of Scgb1a1 expression in the observed
Table 1. Lung Tumors from Induced Mice Carry K-ras Mutation at Position 12.
Exon 1 Exon 2
Tumor sample 1 GGT > CGT wt
Non-tumor sample 1 wt wt
Bronchiolar hyperplasia 1 wt wt
Tumor sample 2 GGT > CGT wt
Non-tumor sample 2 wt wt
Bronchiolar hyperplasia 2 wt wt
Tumor sample 3 GGT > CGT wt
Non-tumor sample 3 wt wt
Bronchiolar hyperplasia 3 wt wt
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bronchiolar hyperplasia may elicit the shutdown of transgene expres-
sion, which can explain the block in progression to overt tumor forma-
tion. Alternatively, in line with a multistep tumorigenesis model,
bronchiolar hyperplasia might require an additional epigenetic or ge-
netic alteration for further progression. In fact, detection of K-rasmuta-
tions (G12R) in all lung tumors but not in bronchiolar hyperplasias
of the DOX-treated (dn E-cadherin–expressing) mice supports this
hypothesis. Moreover, absence of multiple pulmonary tumors in
control animals suggests cooperation between the loss of functional
E-cadherin and oncogenic K-ras in the development of lung cancer.
The cellular heterogeneity within a tumor hampers the identifi-
cation of a cell of origin, particularly if a characteristic cell marker
such as Scgb1a1 is downregulated upon neoplastic conversion and
the cell of interest is phenotypically plastic. Pro Sftpc is often ex-
pressed in lung tumors in mice. Whether this is because tumors arise
from alveolar type II cells or because cancer cells gain pro Sftpc ex-
pression is still unclear. Expression of pro Sftpc in the DOX-treated
tumors in which Scgb1a1 was down-modulated brings an explanation
to the lung tumor animal models in which the candidate oncogene
has been expressed under the control of the Scgb1a1 promoter and
pulmonary tumors with type II cell features were formed. Our recent
publication regarding the formation of bronchiolar hyperplasia that
are negative for Scgb1a1 and positive for pro Sftpc upon conditional
expression of oncogenic C-RAF in Clara cells supports this hypothesis
[44]. In animal model studies, three cell types of pulmonary lineage,
namely, type II pneumocytes, Clara cells, and BASCs, have so far
been identified as cells of origin of lung adenocarcinomas [35]. To
our knowledge, our results provide the first in vivo data in addition
to these cells; NEB-associated naphthalene-resistant Clara cells
(ClaraV) play an important role in the formation of precancerous
lesions, increasing the susceptibility to lung cancer. When compared
to lung tumors, lack of K-ras G12R mutation in precancerous lesions
of DOX-treated mice supports the notion that expansion of stem/
progenitor cells alone is not sufficient for tumorigenesis but requires
at least one further genetic or epigenetic event [45].
Our data demonstrate that E-cadherin is necessary for the homeo-
stasis of the epithelial cells lining the conducting airways. Over-
expression of dn E-cadherin in Scgb1a1-expressing cells resulted in
dramatic reduction in the abundance of two derivatives of bronchiolar
stem cells, the differentiated Clara cell and the terminally differenti-
ated ciliated cell. The lack of differentiated cell types was accompanied
by a corresponding increase in the number of immature epithelial cells
that were identified either as BASC-like progenitor cells or ClaraV
cells. Thus, disruption of cell adhesion between Clara cells of the
steady-state lung potentially generated a population of bronchiolar
stem cells that failed to generate differentiated epithelial cell types.
This might be the potential cause of defective airway regeneration
after injury. Uncontrolled expansion of ClaraV cells following func-
tional loss of E-cadherin in mature Clara cells resulted in bronchiolar
hyperplasia that predisposed the lungs to tumor formation.
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Supplementary Materials and Methods
Mouse Strains
Mice were housed under barrier conditions in air-filtered, temperature-
controlled units with a 12-hour light/dark cycle with free access to food
and water ad libitum. CCSP rtTA and Tet-O dn E-cadherin mice were
previously generated and genotyped as described. The dominant nega-
tive E-cadherin mutant is a truncated form of E-cadherin lacking most
of the extracellular domain inserted with a human c-Myc epitope but
still binds β-catenin [1]. CCSP rtTA mice were maintained on FVB/n
background. Tet-O dn E-cadherin transgenic mice were maintained
on C57Bl/6 background. Compound mice were induced with DOX
(Sigma) containing food (500 mg/kg body weight; Ssniff, Soest,
Germany) for different periods and analyzed for the phenotypic
accuracy of lung pathology. All animal experiments were performed
according to the regulations of the Bavarian State authorities.
RNA Isolation and RT-PCR Analysis
Total RNA was isolated from whole lungs of mice using TRIzol
(Invitrogen, Carlsbad, CA) reagent. Samples were treated with RNase-
free DNAse I before the preparation of c-DNA using random hexamer
primers provided by the First-Strand c-DNA Synthesis Kit (Fermentas,
St Leon-Rot, Germany). Control reactions were run using Taq polymerase
without reverse transcriptase. Real-time RT-PCR was performed using
the DyNAmo HS SYBR Green qPCR Kit (Thermo Fisher Scientific,
Erlangen, Germany) in a Roto-Gene 2000 Detection System (Qiagen,
Hilden, Germany) with previously described primers [2–4]. Values
were calculated by the ΔΔCT method. RNA of hypoxanthine-guanine
phosphoribosyltransferase (HPRT) was used as standard control. Tran-
scriptional activation of the Wnt target genes was determined by semi-
quantitative RT-PCR using total lung RNA. The PCR products were
visualized by electrophoresis in 2% agarose gels. Primer sequences are
available on request.
Immunoblot Analysis
Left lung lobes of mice were homogenized shortly using an Ultra-
Turrax homogenizer in a cold environment. The homogenates were
centrifuged at 11,000 rpm for 10 minutes. After centrifugation,
supernatants from samples were analyzed for protein concentration
by using the NanoDrop ND-1000 (Thermo Fisher Scientific).
The remaining extracts were mixed with 4× Laemmli loading buffer
heated to 95°C for 5 minutes and either stored at −20°C or resolved
by sodium dodecyl sulfate–polyacrylamide gel electrophoresis and
transferred to nitrocellulose membranes. After 1-hour blocking with
5% non-fat dry milk in NET-gelatin (50 mM Tris/HCl (pH 7.4),
5 mM EDTA, 0.05% Triton X-100, 150 mMNaCl, 0.25% gelatin],
blots were incubated overnight at 4°C with primary antibodies
subsequently washed three times with NET-gelatin and incubated
for 1 hour at room temperature with peroxidase-coupled secondary
antibodies (GE Healthcare, Freiburg, Germany). After three washes
with NET-gelatin, blots were developed using ECL kit (Thermo
Fisher Scientific). Immunoblot analysis was performed using the
following antibodies: myc tag (9E10, 1:100; Santa Cruz Biotech-
nology, Offenbach, Germany), actin (I-19, 1:3000; Santa Cruz
Biotechnology), E-cadherin (clone ECCD2, 1:250; Zymed Labora-
tories, Darmstadt, Germany), vimentin (clone D21H3, 1:500; Cell
Signaling Technology, Frankfurt, Germany), Slug (clone C19G7,
1:500), N-cadherin (clone 3B9, 1:1000; Invitrogen), c-Myc (clone
D84C12, 1:250), cyclin D1 (clone H-295, 1:500; Santa Cruz
Biotechnology), TCF1 (clone C63D9, 1:1000; Cell Signaling
Technology), β-catenin (clone D10A8, 1:1000), and active β-catenin
(clone D13A1, 1:500; Cell Signaling Technology).
Histopathology and Immunostainings
Mouse lungs were dissected and fixed with 4% paraformaldehyde
in phosphate-buffered saline (PBS) overnight at 4°C. The tissue sam-
ples were rinsed in PBS, dehydrated, and then embedded in paraffin
blocks. Six-micrometer tissue sections were deparaffinized, rehydrated
in graded series of alcohol, and hematoxylin and eosin (H&E) stained
using standard procedures. For immunohistochemistry, sections were
deparaffinized and rehydrated. For antigen retrieval, sections were in-
cubated in 10 mM citrate buffer for 10 and 20 minutes using micro-
wave irradiation. Endogenous peroxidase activity was quenched with
methanol or PBS containing 1% and 3% H2O2. Non-specific binding
was blocked with 5% of serum for 1 hour. After blocking, sections were
incubated with primary antibodies overnight at 4°C. Immunohisto-
chemistry and immunofluorescent staining was performed using the
following antibodies at the indicated dilutions: CYP2F2 (sc-67283,
1:200; Santa Cruz Biotechnology), CCSP (sc-9772, 1:2500; Santa
Cruz Biotechnology), Ki67 (MM1, 1:50; Vector Laboratories, Lörrach,
Germany), pro SpC (gift of Jeffrey A. Whitsett), TTF-1 (M3575,
1:100; DakoCytomation, Hamburg, Germany), vimentin (C-20,
1:200; Santa Cruz Biotechnology), E-cadherin (clone ECCD2, 1:250;
Zymed Laboratories), E-cadherin (clone 24E10, 1:250; Cell Signaling
Technology), phospho-Akt (4060, 1:50; Cell Signaling Technology),
phospho-ERK (4376, 1:100; Cell Signaling Technology), active
β-catenin (clone 8E7, 1:100; Millipore, Schwalbach, Germany),
myc tag (9E10, 1:100; Santa Cruz Biotechnology), acetylated tubulin
(T7451, 1:5000; Sigma), PGP 9.5 (7863-0504, 1:5000; AbD Serotec),
β-catenin (06-734, 1:100; Upstate Biotechnology, Lake Placid, NY).
Following primary antibody incubation, sections were incubated with
the corresponding biotinylated secondary antibodies (DakoCytomation)
at a 1:200 dilution for 60 minutes at room temperature. ABC reagent
was applied (Vectastain Elite ABX Kit; Vector Laboratories, Burlingame,
CA) and developed in DAB. Sections were then counterstained with
hematoxylin and mounted after dehydration. Phospho-p44/p42
mitogen-activated protein kinase (MAPK) staining was essentially car-
ried out as the others except that TBS with 1% Tween 20 was used
instead of PBS. CCSP and pro SpC dual immunofluorescence staining
was done as previously described [5]. For immunofluorescence staining,
the following secondary antibodies (all obtained from Jackson Immuno-
Research Laboratories, West Grove, PA, at 1:200 dilutions) were used:
donkey anti-mouse Cy3, donkey anti-mouse Cy5, donkey anti-goat
Cy5, donkey anti-goat Cy3, donkey anti-rabbit Cy3, donkey anti-rabbit
Cy5, donkey anti-rabbit Alexa 488, donkey anti-rat Cy3, donkey anti-
rat Cy5. For Alcian Blue staining, lung sections were deparaffinized,
rehydrated in graded series of alcohols, and incubated in Alcian Blue
(pH 2.5, Sigma) solution for 30 minutes at room temperature. After
washing in tap water for 5 minutes, sections were counterstained with
Nuclear Fast Red (Sigma) for 5 minutes, washed with tap water for
3 minutes, dehydrated, and mounted with Entellan. For microscopy,
we employed the Zeiss Axio Scope.A1 or the Zeiss Discovery.V8 Stereo
microscopes (Carl Zeiss MicroImaging GmbH) integrated with an
AxioCam ICc3 camera (Spectra Service). Images were acquired using
AxioVision Rel. 4.7 software provided by Zeiss. Negative controls
included the omission of the primary antibody.
Morphometric Analysis
Quantitation of ciliated cells was assessed by determining the length
of basement membrane underlying tubulin+ regions of the epithelium
and dividing this value by the total length of the basement membrane.
Ciliated cells were scored from at least 10 bronchioles per lung. At least
four mice for each group were counted. Epithelial repair was quantified
at day 2 and day 18 recovery time points by determining the length of
basement membrane underlying CYP2F2+ or CCSP+ regions of the
epithelium and dividing this value by the total length of the basement
membrane. The length of the bronchial epithelium was determined us-
ing the measurement function of Zeiss Axio Scope.A1. For quantitative
assessment of NEB-associated PNECs or ClaraV cell proliferation, triple
immunofluorescence staining was performed on lung sections using
CGRP, CCSP, and Ki-67 antibodies. ClaraV cells were identified with
their association with CGRP-expressing neighboring NE cells.
Naphthalene Exposure
Five-week-old male compound (CCSP rtTA/Tet-O dn E-cadherin)
mice were intraperitoneally injected with 250 mg/kg body weight of
naphthalene (Sigma) dissolved in corn oil. Animals were sacrificed 2
or 18 days following naphthalene or corn oil treatments.
BASC Sorting by Flow Cytometry
BASCs were isolated from the lungs of 6-week-old DTR mice
according to established protocols [6]. Briefly, mice were sacrificed,
and their lungs were removed and cut into small pieces. Tissue dis-
sociation was performed by treating with Dispase (Invitrogen) at room
temperature for 60 minutes, then passing the lungs through 100-, 70-,
and 40-μM filters to obtain a single-cell suspension. After washing with
PBS, cells were stained with phycoerythrin (PE)-conjugated anti-CD45
and anti-CD31 (eBioscience, San Diego, CA), fluorescein isothiocyanate–
conjugated anti-CD34, and subsequently with PE-CY5–conjugated
anti-Sca1. After a 30-minute incubation, cells were washed three times
and sorted using fluorescence-activated cell sorting (FACS). Flow cytom-
etric analysis was performed on a FACSCalibur (BD Immunocytometry
Systems) according to the manufacturer’s instructions.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism 5
software (GraphPad Software, Inc). Student’s t test (two-tailed)
was used to compare two groups. When more than two groups were
compared, differences among the groups were determined by one-
way analysis of variance. Differences between means were considered
statistically significant when P < .05.
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Figure W1. Analysis of subcellular distribution of endogenous
E-cadherin in conducting airway cells after dn E-cadherin expres-
sion. Representative dual immunofluorescence staining of lung sec-
tions from induced DTR mice for myc tag (red) and E-cadherin
(green). Images are representative of n = 3 separate mice per treat-
ment group. Arrows indicate myc tag–expressing cells that are neg-
ative for E-cadherin. Nuclei were counterstained with DAPI (blue).
Figure W2. Analysis of CCSP and E-cadherin expression in con-
ducting airways after naphthalene treatment. Dual immunofluores-
cence staining of lung sections for CCSP (red) and E-cadherin
(green). Images are representative of n = 3 separate mice per
treatment group. Five-week-old mice were treated as indicated.
Mice were recovered following 2 days from naphthalene exposure.
Arrows indicate naphthalene-resistant Clara cells.
Figure W3. Analysis of the transgene expression in induced hyper-
plastic lesions. Double immunofluorescence staining of a repre-
sentative lung section from an induced mouse for the indicated
markers shows that only minority of the hyperplastic cells express
the transgene.
Figure W4. (A) β-Catenin immunohistochemistry and analysis of abundance of alveolar type II cells in the hyperplasia. (A) Paraffin-
embedded lung sections from induced DTR mice stained for β-catenin (brown). Right panel pictures are the high magnification of
the insets. Hematoxylin (blue) was used as a counterstain. (B) Double immunofluorescence staining of a representative hyperplastic
lesion for CCSP (red) and pro SpC (green) shows that most of the cells in the hyperplasia are negative for pro SpC. Nuclei were counter-
stained with DAPI (blue). Dotted lines outline the hyperplastic area.
Figure W5. Analysis of abundance of ciliated and goblet cells in induced bronchiolar hyperplasia. (A) Double immunofluorescence stain-
ing of lung sections from induced mice for indicated markers. Nuclei were counterstained with DAPI (blue). White arrows and the marked
region show early and progressive bronchiolar hyperplasia, respectively. (B) Alcian Blue 2.5 staining of lung sections from control (OFF
DOX) and induced (ON DOX) mice. Green arrows show Alcian Blue–positive goblet cells. Blue arrows and the marked regions show early
and progressive bronchiolar hyperplasias, respectively.
Figure W6. Early lung tumors in induced DTR mice resemble the
papillary hyperplastic lesions and are associated with conducting
airways. (A) Histologic analysis through H&E staining of lungs from
DOX-treated DTR mice showing the epithelial hyperplasia (arrows).
(B) H&E staining of a lung section from a 7-month DOX-treated
mouse shows a budding lung tumor (arrow) from a bronchiole.
Figure W7. Analysis of transgene, phospho-ERK, and phospho-Akt expression in induced lung tumors. (A) To distinguish spontaneous
lung tumors from induced tumors, we performed immunohistochemistry for myc tag on lung sections. Red arrows show myc tag–
expressing rare tumor cells in an induced lung tumor. Note the absence of myc tag staining in the spontaneous lung tumor. High-
magnification image represents the region shown in the inset. Hematoxylin (blue) was used as a counterstain. Immunohistochemistry
of lung tumor sections from a 10-month-old mouse for pERK (B) and for pAkt (C). Hematoxylin (blue) was used as a counterstain.
Figure W8. Lack of EMT-associatedmarkers in induced lung tumors.
Western blot analysis of a lung tumor from an induced mouse was
probed against the indicated markers for evaluation of EMT activa-
tion. A mouse NSCLC cell line (3041) transfected with a stabilized
form of β-catenin (4S) was used as positive control for the markers.
